In the present study, we tested whether 8SPT changes the gene expression of the ischemic myocardium, and furthermore, we discuss the feasibility and applicability of the cDNA array technique to understanding the adenosineinduced cardioprotection against ischemia and reperfusion.
Methods
Forty-one MCH/ICR male mice of 2.5-months of age weighing 25-34 g were assigned to 4 groups: the myocardial ischemia groups, (1) with (n=9) and (2) without 8SPT (n=9), (3) 8SPT (n=9) and (4) the control group (n=9). All mice were anesthetized with pentobarbital (60 mg/kg, ip), and were artificially ventilated. 8SPT was administered (10 mg/kg, ip) 20 min before anesthesia. After opening the chest and pericardium, we placed an 8-0 nylon suture around the proximal site of the left coronary artery (LCA). In the myocardial ischemia groups, 20 min after the anesthesia, we ligated the LCA for 60 min. In the control group, we waited for 60 min without occluding the LCA. After these procedures, the hearts were excised and the atrium was removed immediately for extraction of the mRNA for the cDNA array analysis. Three hearts in the each group were combined and the mRNA were extracted; that is, 3 sets were separately hybridized to the different membranes.
Osaka, Japan; Genome Systems Inc, St Louis, MO, USA). The information about the position of the cDNA spotted on the filter is obtained by accessing http://www.genome systems.com/GDA/. Each filter was spotted with approximately 18,000 non-redundant murine cDNA clones from the I.M.A.G.E. collection that were re-arrayed into 384-well culture dishes. These cultures were gridded onto a nylon membrane in a double-spotted pattern at a density of 36,864 spots per filter or 18,376 individual cDNA clones, 32 controls, and 24 orientation markers. Run-off RNA corresponding to the Arabidopsis and Drosophila internal controls was also spotted on the filters. These RNAs were labeled separately and were combined with sample firststrand cDNA probes. The data from these spots can be plotted with hybridization intensity versus the RNA amount. The slope of the line is used to normalize the hybridization intensities of all the spots on a filter in order to compare these signals with those from other filters.
cDNA Probe and Control Preparation
Purified mRNA from each murine heart was ethanol precipitated and re-suspended in RNAase free water. Each mRNA of 2.5 g was mixed with 50 mol/L oligodT and incubated at 70°C for 10 min. After cooling on ice, mRNA was lypholized on low heat until dry and reverse-transcribed in 1.4 l 5XMMLV buffer (Promega, 0.4 l of 10 mmol/L dA/dG/dT mix (Ambion TX, USA), 4 l [alpha-33 P]dCTP (NEN, Dupon) and 1.2 l MMLV (Promega). After incubation at 42°C for 1 h, the mRNA was degraded by adding 12.5 l of 1 mol/L NaOH. Unincorporated nucleotide and degraded RNA were removed from the labeled probe with a G-50 spin column.
Hybridization
The filters were prehybridized with 15 ml NorthernMax hybridization buffer (Ambion) at 42°C for 4 h. After draining the pre-hybridization buffer, the probe/control mixture was added, mixed well, and hybridized at 42°C for 14 h. After hybridization, the filters were rinsed with 2 × SSC at room temperature for 5 min once, and 2 × SSC / 1%SDS at 68°C for 30 min 3 times. After the rinses, the filters were imaged on a phosphorimager MD STORM  and analyzed with Genome Discovery Software (Genome Systems, Inc).
Analysis of the Filters
Two spots of the same cDNA on the filter were averaged. To compare the spots on 2 filters, the intensity of each spot was normalized with the control spots. The ratio between one spot and the corresponding spot greater than 5.0 was considered as significantly expressed. 7
Results
Five mice died during induction of the ischemia in the with (n=4) and without (n=1) 8SPT groups.
In 18,376 cDNA, 2 and 11 known genes were upregulated 10-20-fold and 5.0-9.9-fold, respectively. 8SPT reduced the expressed genes to the control levels. Furthermore, 32 unknown genes were also upregulated over 5.0-fold. In contrast, 11 known genes were downregulated below 0.2-fold, and 64% of the downregulated genes were restored by 8SPT. The 7 unknown genes were downregulated to level below 0.2-fold. Table 1 shows the up-or downregulated genes in the ischemic hearts, and the effects of 8-SPT on the modulation of genes. 8-SPT itself did not significantly alter the gene expression in all of cDNA in the non-ischemic hearts ( Table 2) .
Discussion

Physiological Importance of the Present Study
Up until now it has been difficult to investigate the changes in gene expression when an intervention is imposed on the hearts. The present study is a good example of investigating how one cardioprotective agent acts in the heart. We tested the effect of adenosine in the ischemic myocardium and obtained an answer to this difficult question. The present study extends the unique idea of investigating gene expression to all of the fields of cardiology.
Interpretation of the Present Study
We have shown how many and what kind of genes are expressed by ischemic stress in the murine heart, and have found that the expression of a substantial number of genes is modulated by endogenous adenosine in the ischemic heart. However, we need to consider the role of the substances produced by the endogenous adenosine-induced gene expression in the pathophysiology of the ischemic heart. Adenosine is known to be cardioprotective: it can trigger and mediate the infarct size-limiting effect of ischemic preconditioning 2, 3 and itself limits the infarct size and extent of myocardial stunning. Thus, we examined whether endogenous adenosine modulates the expression of cDNAs in the ischemic hearts. 8SPT attenuated the increase in the expression of several genes, which may partially explain the cardiovascular effects of adenosine in the ischemic heart. Although we do not know the exact mechanisms of how adenosine exerts its cardioprotection, we now have a clue.
First of all, the present study revealed that adenosine is responsible for the expression of cytochrome P450, the key enzyme in the production of endothelium-derived hyperpolarizing factor (EDHF). This observation suggests a tight linkage between adenosine and EDHF that may contribute to the attenuation of ischemic injury. 9 Furthermore, the components of the thyroid hormone receptor systems were also upregulated in the ischemic heart. The thyroid hormones have been reported to be cardioprotective: thyroid hormone improves the coupling of glycolysis to glucose oxidation, and thereby decreases H + production and increases cardiac metabolic efficiency; 10 it also decreases the severity of myocardial stunning, 11 and stimulates angiogenesis in the ischemic rat heart; 12 thyroid hormone may also be related to cardiac remodeling after acute ischemia. 13 Therefore, the upregulation of the thyroid hormone receptor system in the ischemic heart seen in the present study may be self-defensive against ischemic injury, and enhancement of the thyroid receptor systems may be a possible therapy for ischemia. The important information in the present study is that upregulation of thyroid hormone system is attributable to endogenous adenosine.
Recently, it has been shown that IFRD1 (interferonrelated developmental regulator 1), which was named the PC4 gene, is necessary for muscle differentiation and might have a role in the signal transduction of cardiomyocytes. 14, 15 Furthermore, a recent study revealed that differentiated cardiomyocytes can be observed in the boundary regions of a necrotic area of the myocardium. 16 Taken together, these observations suggest the possible differentiation of cardiomyocytes in the ischemic region influenced by IFRD1 and the adenosine linkage shown in the present study.
On the other hand, several cDNAs were downregulated, which may also contribute to the pathophysiology. For example, p52 pro-apoptotic protein is downregulated, suggesting that the apoptotic process in the ischemic heart is attenuated, 17 and that endogenous adenosine may be related to this phenomenon. Several investigators have suggested that apoptosis is involved in the pathophysiology of the ischemic heart. 18, 19 On the other hand, the downregulation of the integral membrane glycoprotein may decrease the membrane integrity, and enhances ischemic injury; 20 adenosine may limit the disruption of membrane integrity via its inhibition of the downregulation of glycoprotein. There were also cDNA expressions that have not been reported to increase during ischemia, and it will be intriguing to examine the physiological significance of the expression of these genes.
Study Limitations
First of all, the reproducibility of the changes in the gene expression is an important factor. Seventy per cent of positive clones were confirmed to be increased by Northern blotting. 7 Second, because we obtained the samples of heart muscle after 60 min of ischemia, the expression of cDNA may be different when the severity of ischemia changes. However, even if the duration of ischemic stress changes, the sequelae are not discrete, but continuous. Indeed, Northern blot analysis revealed that the gene expressions that were increased using the cDNA array peak expressions at 15 or 30 min, continued to be expressed at 60 min of ischemia. 7 Therefore, the present results may be applicable to shorter or longer periods of ischemia.
Third, we used the samples of the whole hearts, so the mRNA in the samples came from cardiomyocytes, endothelial cells, smooth muscles, blood cells and fibroblasts. We could not differentiate which cells were responsible for the gene expression of certain substances in the present study, and we need to examine the expression of each gene in each cell type. We confirmed that we could not detect the gene expression of the necrotic area, 7 which leads to the idea that the gene expression observed in the present study is attributable to the ischemia area without necrosis and the nonischemic area.
Lastly and importantly, there is an argument that that cDNA array indicates only observable facts, but may not present a definite conclusion, which may limit the value of the present study. Indeed, we only showed identified by name those genes that were modulated by the adenosine receptor antagonist. The present results are not conclusive evidence that adenosine enhances VEGF expression, 8 but we believe that the amount of information that can be obtained with the cDNA array method is huge, whether or not these data per se are informative. For example, researchers who are interested in thyroid hormone and cardioprotection may consider that the cardioprotection conferred via thyroid hormone is attributable to adenosine because the present study revealed that the thyroid hormone system is largely influenced by adenosine (Table 1) . Therefore, the present study is not hypothesis testing, but is observatory science. As observation was important at the beginning of the physical and chemical sciences, it is also important to present such results at this premature stage of molecular science.
Conclusion
In summary, we can provide information about endogenous adenosine-related up-or downregulation of many cDNAs for proteins or enzymes possibly related to ischemia and reperfusion injury, and we propose a new strategy for investigating the pathophysiology of ischemic injury. Further steps are definitely necessary before a conclusive cause -effect relationship between the adenosine-induced changes in gene expression and the pathophysiology of the ischemic heart can be presented.
